Pacira BioSciences, Inc. PCRX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s investment purchases?
- Pacira BioSciences, Inc. (PCRX) reported investment purchases of $0 in Q1 2026.
- How has Pacira BioSciences, Inc.'s investment purchases changed year-over-year?
- Pacira BioSciences, Inc.'s investment purchases decreased by 100.0% year-over-year, from $69.63M to $0.
- What is the long-term trend for Pacira BioSciences, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s investment purchases has grown at a -30.7% compound annual growth rate (CAGR), from $611.49M to $141.04M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.